https://heartrisa.com/heartrisa/blog Long-form guides on cardio-oncology, survivorship care, regional strategy, the Annual Summit, and the multi-stakeholder collaborative model. en-us Wed, 26 Aug 2026 00:00:00 GMT https://heartrisa.com/heartrisa/blog/how-sponsors-partner-effectively-with-heartrisa https://heartrisa.com/heartrisa/blog/how-sponsors-partner-effectively-with-heartrisa Wed, 26 Aug 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Collaborative Model sponsorship partnership industry operations The best HeartRisa sponsors treat the collaborative as an operating partner, not a marketing channel. Here is the pattern that consistently works. https://heartrisa.com/heartrisa/blog/survivorship-care-plan-template-guide https://heartrisa.com/heartrisa/blog/survivorship-care-plan-template-guide Sat, 22 Aug 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Survivorship care plan template survivorship clinician tools Most survivorship care plans mention the heart in a paragraph. A cardio-oncology-grade plan makes it a whole section. Here is what should be in it — and why. https://heartrisa.com/heartrisa/blog/innovation-marketplace-explained https://heartrisa.com/heartrisa/blog/innovation-marketplace-explained Tue, 18 Aug 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Innovation marketplace innovation vendors vetting The Innovation Marketplace is where survivors and clinicians access vetted technologies and services — and where innovators reach the collaborative's implementation network. https://heartrisa.com/heartrisa/blog/annual-summit-what-to-expect-2027 https://heartrisa.com/heartrisa/blog/annual-summit-what-to-expect-2027 Fri, 14 Aug 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Annual Summit summit 2027 programming tracks A first look at the 2027 HeartRisa Annual Summit — the year's themes, working tracks, and how survivors, clinicians, researchers, and sponsors can plan their participation. https://heartrisa.com/heartrisa/blog/regional-strategy-urban-safety-net-hospitals https://heartrisa.com/heartrisa/blog/regional-strategy-urban-safety-net-hospitals Mon, 10 Aug 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Regional Strategy urban safety-net equity regional Urban safety-net hospitals treat some of the highest-risk cancer survivors in the country. HeartRisa's strategy meets them with practical, funded partnerships — not just guidelines. https://heartrisa.com/heartrisa/blog/regional-strategy-southeast-us-cardio-oncology https://heartrisa.com/heartrisa/blog/regional-strategy-southeast-us-cardio-oncology Thu, 06 Aug 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Regional Strategy southeast regional health equity community engagement The Southeast has among the highest US rates of both cardiovascular disease and cancer mortality. Here is HeartRisa's regional strategy for closing that survivorship gap. https://heartrisa.com/heartrisa/blog/digital-twins-cardio-oncology https://heartrisa.com/heartrisa/blog/digital-twins-cardio-oncology Sun, 02 Aug 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Innovation digital twin AI risk prediction personalized medicine Patient-specific digital twin models are moving from research to pilot deployments. Here is how they might reshape cardio-oncology risk prediction — and where the hype exceeds the evidence. https://heartrisa.com/heartrisa/blog/immunotherapy-myocarditis-survivorship https://heartrisa.com/heartrisa/blog/immunotherapy-myocarditis-survivorship Tue, 28 Jul 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Cardio-Oncology immunotherapy checkpoint inhibitors myocarditis rare adverse events Immune checkpoint inhibitors have transformed oncology — and introduced a rare but serious cardiac complication. Survivors and their care teams should know the warning signs. https://heartrisa.com/heartrisa/blog/anthracycline-cardiotoxicity-prevention https://heartrisa.com/heartrisa/blog/anthracycline-cardiotoxicity-prevention Fri, 24 Jul 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Cardio-Oncology anthracyclines cardiotoxicity prevention evidence Anthracyclines are still workhorses of chemotherapy — and still the classic cardiotoxic offender. Here is what current evidence supports for prevention. https://heartrisa.com/heartrisa/blog/wearables-in-cardio-oncology-survivorship https://heartrisa.com/heartrisa/blog/wearables-in-cardio-oncology-survivorship Mon, 20 Jul 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Innovation wearables digital health monitoring survivorship Smart watches, patches, and continuous monitors are everywhere — but only a handful of use cases have real evidence behind them for cancer survivors. Here is the honest map. https://heartrisa.com/heartrisa/blog/preparing-for-the-heartrisa-annual-summit https://heartrisa.com/heartrisa/blog/preparing-for-the-heartrisa-annual-summit Thu, 16 Jul 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Annual Summit summit attendees playbook The HeartRisa Annual Summit brings the full survivorship ecosystem into one room. Here is how first-time attendees — survivors, clinicians, sponsors — can get the most from it. https://heartrisa.com/heartrisa/blog/how-multi-stakeholder-councils-accelerate-survivorship-research https://heartrisa.com/heartrisa/blog/how-multi-stakeholder-councils-accelerate-survivorship-research Tue, 14 Jul 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Collaborative Model councils research governance Multi-stakeholder councils — survivors, clinicians, researchers, industry, community — shorten the distance between research question and real-world impact. Here is why the structure works. https://heartrisa.com/heartrisa/blog/inside-the-heartrisa-ecosystem https://heartrisa.com/heartrisa/blog/inside-the-heartrisa-ecosystem Fri, 10 Jul 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Collaborative Model ecosystem governance COIM The HeartRisa Collaborative is built on a nine-member ecosystem, each with a distinct role — from clinical innovation to workforce development to technology infrastructure. Here is how the pieces fit. https://heartrisa.com/heartrisa/blog/cardio-oncology-101-heart-health-after-cancer https://heartrisa.com/heartrisa/blog/cardio-oncology-101-heart-health-after-cancer Sun, 05 Jul 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Cardio-Oncology primer survivorship prevention Cardiovascular disease is a leading cause of death in cancer survivors. Cardio-oncology is the specialty built to change that. Here is what survivors and clinicians should know. https://heartrisa.com/heartrisa/blog/what-is-a-survivorship-innovation-collaborative https://heartrisa.com/heartrisa/blog/what-is-a-survivorship-innovation-collaborative Wed, 01 Jul 2026 00:00:00 GMT editorial@heartrisa.com (HeartRisa Editorial) Collaborative Model collaborative governance survivorship COIM A survivorship innovation collaborative connects survivors, clinicians, researchers, and industry to accelerate cardio-oncology outcomes. Here is how the HeartRisa model works.